Rekrutierungsübersicht
(Stand Oktober 2020)
Chronologische Übersicht und Anzahl der rekrutierten Patienten
| Studie | Rekrutierungszeitraum | Zahl der rekrutierten Patienten |
|---|---|---|
| HD1 | 09/82 – 02/88 | 180 |
| HD2 | 04/83 – 09/87 | 23 |
| HD3 | 10/82 – 02/88 | 299 |
| HD4 | 03/88 – 04/94 | 499 |
| HD5 | 02/88 – 02/93 | 1124 |
| HD6 | 03/88 – 01/93 | 1124 |
| HD7 | 01/94 – 06/98 | 650 |
| HD8 | 02/93 – 03/98 | 1204 |
| HD9 | 02/93 – 03/98 | 1282 |
| HD10 | 05/98 – 01/03 | 1370 |
| HD11 | 05/98 – 01/03 | 1570 |
| HD12 | 01/99 – 01/03 | 1670 |
| HD13 | 01/03 – 09/09 | 1710 |
| HD14 | 01/03 – 12/09 | 2056 |
| HD15 | 01/03 – 04/08 | 2182 |
| PVAG14 | 08/08 – 05/11 | 41 |
| HD16 | 11/09 – 12/15 | 1150 |
| HD17 | 12/11 – 03/17 | 1100 |
| HD18 | 05/08 – 07/14 | 2101 |
| AVD-REV | 04/10 – 11/12 | 23 |
| Ofatumumab | 07/11 – 02/14 | 28 |
| HD-R3i Phase I | 08/12 – 01/14 | 14 |
| HD-R3i Phase II | 07/14 – 03/18 | 59 |
| Targeted BEACOPP | 10/12 – 03/14 | 103 |
| GHSG-AFM13 | 06/15 – 06/19 | 25 |
| JeRiCHO | 10/15 – 03/18 | 14 |
| B-CAP | 09/15 – 10/18 | 70 |
| IRENO | 08/16 – offen | 15 |
| HD21 | 07/16 – 08/20 | 1500 |
| HD21-Elderly Kohorte | 06/20 – offen | 9 |
| NIVAHL | 04/17 – 10/18 | 110 |
| BV-Allo | 11/19 – offen | 2 |
| AERN | 12/19 – offen | 7 |